Recurrent Colorectal Adenocarcinoma
2 clinical trials · Condition
◉ Watch Recurrent Colorectal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer (NCT06102902) | National Cancer Institute (NCI) | 2024-06-05 |
| TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study (NCT04109924) | Roswell Park Cancer Institute | 2019-12-27 |
Track Recurrent Colorectal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.